Correcetions to "A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS)".
暂无分享,去创建一个
M. Piccart | U. Dafni | E. D. de Vries | R. Sullivan | C. Zielinski | J. Kerst | A. Sobrero | N. Cherny